Landskroner K[au] - Search Results

Year	Number of Results
2001	1
2004	2
2005	2
2011	2
2012	1
2015	1
2020	1
2023	0

1

Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics.

Landskroner KA, Hess P, Treiber A. Landskroner KA, et al. Xenobiotica. 2011 Aug;41(8):687-700. doi: 10.3109/00498254.2011.569772. Epub 2011 Apr 13. Xenobiotica. 2011. PMID: 21486193 Review.

2

Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?

Novokhatny VV, Jesmok GJ, Landskroner KA, Marder VJ, Zimmerman TP. Novokhatny VV, et al. Among authors: landskroner ka. Trends Pharmacol Sci. 2004 Feb;25(2):72-5. doi: 10.1016/j.tips.2003.12.009. Trends Pharmacol Sci. 2004. PMID: 15102492 Review.

3

Identification of Patient Needs and Preferences in Pigmented Villonodular Synovitis (PVNS) Using a Qualitative Online Bulletin Board Study.

Cook NS, Landskroner K, Shah B, Walda S, Weiss O, Pallapotu V. Cook NS, et al. Among authors: landskroner k. Adv Ther. 2020 Jun;37(6):2813-2828. doi: 10.1007/s12325-020-01364-4. Epub 2020 May 11. Adv Ther. 2020. PMID: 32394210 Free PMC article.

4

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.

Iglarz M, Landskroner K, Bauer Y, Vercauteren M, Rey M, Renault B, Studer R, Vezzali E, Freti D, Hadana H, Schläpfer M, Cattaneo C, Bortolamiol C, Weber E, Whitby BR, Delahaye S, Wanner D, Steiner P, Nayler O, Hess P, Clozel M. Iglarz M, et al. Among authors: landskroner k. J Cardiovasc Pharmacol. 2015 Nov;66(5):457-67. doi: 10.1097/FJC.0000000000000296. J Cardiovasc Pharmacol. 2015. PMID: 26230396 Free PMC article.

5

Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist.

Bruderer S, Aänismaa P, Homery MC, Häusler S, Landskroner K, Sidharta PN, Treiber A, Dingemanse J. Bruderer S, et al. Among authors: landskroner k. AAPS J. 2012 Mar;14(1):68-78. doi: 10.1208/s12248-011-9316-3. Epub 2011 Dec 22. AAPS J. 2012. PMID: 22189899 Free PMC article. Clinical Trial.

6

Thromboelastography measurements of whole blood from factor VIII-deficient mice supplemented with rFVIII.

Landskroner KA, Olson NC, Jesmok GJ. Landskroner KA, et al. Haemophilia. 2005 Jul;11(4):346-52. doi: 10.1111/j.1365-2516.2005.01104.x. Haemophilia. 2005. PMID: 16011586

7

Enhanced factor VIII activity measurements using ROTEG and factor VIII-/- mice whole blood.

Landskroner KA, Olson NC, Jesmok GJ. Landskroner KA, et al. J Thromb Haemost. 2004 Dec;2(12):2274-5. doi: 10.1111/j.1538-7836.2004.01074.x. J Thromb Haemost. 2004. PMID: 15613052 Free article. No abstract available.

8

Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.

Landskroner K, Olson N, Jesmok G. Landskroner K, et al. J Vasc Interv Radiol. 2005 Mar;16(3):369-77. doi: 10.1097/01.RVI.0000148828.40438.D3. J Vasc Interv Radiol. 2005. PMID: 15758133

9

Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.

Marder VJ, Landskroner K, Novokhatny V, Zimmerman TP, Kong M, Kanouse JJ, Jesmok G. Marder VJ, et al. Among authors: landskroner k. Thromb Haemost. 2001 Sep;86(3):739-45. Thromb Haemost. 2001. PMID: 11583303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results